<DOC>
	<DOC>NCT00418366</DOC>
	<brief_summary>A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication</brief_summary>
	<brief_title>A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Inclusion Criteria : Male and nonpregnant females with a clinical diagnosis of renal insufficiency with mild, moderate, severe or end stage renal disease on hemodialysis A body mass index of less than 40 kg per meter squared (body weight in kg divided by height in meters squared) Smokes less than 10 cigarettes/day Exclusion Criteria : Patients with uncontrolled diabetes or uncontrolled congestive heart failure Patient has abnormal prestudy laboratory measurements including serum potassium or white blood counts Patient has systolic blood pressure below 100 mm Hg or above 180 mm Hg Patient has diastolic blood pressure less than 50 mm Hg systolic or above 100 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Mild, moderate, severe renal insufficiency</keyword>
	<keyword>End stage renal disease</keyword>
</DOC>